Latest news with #DGL
National Business Review
3 days ago
- Business
- National Business Review
DGL warns 2025 profit will be down 55-65%
ASX-listed trans-Tasman chemicals and logistics company DGL has warned its net profit after tax in the 2025 financial year will be significantly below 2024. The company said today that its revenue was on track to be slightly higher this year, against the A$466.1 million it reported for the year
Miami Herald
06-05-2025
- Health
- Miami Herald
The Bloat Stops Here: Neue Theory Introduces Digest + Debloat, a Science-Backed, Woman-Formulated Supplement for Sensitive Guts
Press Releases The Bloat Stops Here: Neue Theory Introduces Digest + Debloat, a Science-Backed, Woman-Formulated Supplement for Sensitive Guts Neue Theory's DIGEST + DEBLOAT Now Available at Neue Theory, the gut-first wellness brand founded by Registered Dietitian Abbey Sharp, is redefining self-care with the launch of its latest innovation: Digest + Debloat. This targeted digestive enzyme supplement tackles bloating at the source - before it starts - combining clinically backed enzymes with calming herbal extracts. It's the second release in Neue Theory's growing product line and a bold continuation of the brand's belief that Gut Care is Self-Care. "Your gut is the foundation of how you feel: physically, mentally, and emotionally," said Abbey Sharp, Registered Dietitian, co-founder and CEO of Neue Theory. "As someone who's lived with IBS for years, I created Digest + Debloat to be the supplement I wish I had: one that's gentle and that actually works. It targets the various root causes of bloating and digestive discomfort with clinically backed ingredients I trust and use every day." With over 70% of women reporting frequent digestive discomfort and IBS affecting nearly twice as many women as men, Digest + Debloat was specifically designed with women's needs in mind - but its science-backed formula makes it a great option for anyone looking to reduce bloating and improve digestion, regardless of gender. Digest + Debloat combines three potent digestive enzymes that target common IBS triggers, like dairy, beans, legumes and other common FODMAP foods, stopping gas, bloating and poor digestion before they start. These enzymes work synergistically with powerful anti-inflammatory ingredients including ginger, chamomile, DGL licorice, fennel seed and curcumin, that work to promote gentle motility, calm gut spasms, and reduce irritation for more comfortable digestion. Digest + Debloat is available now in a 90-capsule bottle for a one-time purchase of $39 USD/$49 CAD or by subscription at 10% off with automatic delivery every 30 or 45 days. Neue Theory launched in 2024 with its debut product: a 2-in-1 Probiotic Protein Powder that quickly earned rave reviews for its science-backed formulation, delicious flavor, and results you can feel. The plant-based powder delivers complete nutrition and gut support, combining pea and hemp protein, clinically studied probiotics (including Bacillus coagulans SNZ 1969 and OPTIBIOME® Bacillus subtilis BS50), and gut-loving extras like L-glutamine, digestive enzymes, ashwagandha, tart cherry, and MCTs. Fueled by strong customer demand and a fast-growing community that values transparency and trust, Neue Theory is building momentum with the launch of Digest + Debloat, solidifying its place as a go-to brand for women seeking smarter, science-first, gut health solutions. Digest + Debloat is now available at ABOUT ABBEY SHARP Abbey Sharp is a Registered Dietitian (RD), award-winning author, founder of Abbey's Kitchen, creator of the Hunger Crushing Combo™, co-founder of Neue Theory™, and mother of two. Blending science with sass, Abbey has established herself as a credible voice in the nutrition, health, and wellness space. Abbey's core philosophy is that a pleasurable relationship with food, your body and yourself is the fundamental secret to good health. From delicious healthy recipes, digital video content, real mom truths and cheeky nutrition myth-busting, Abbey Sharp has become the go-to source for entertaining, informative, and inspirational lifestyle content to well over two million loyal followers. ABOUT NEUE THEORY Neue Theory is a wellness brand on a mission to bring clarity to the supplement aisle and gut health to the forefront. Co-founded by Registered Dietitian Abbey Sharp and entrepreneur Ginger Bertrand, Neue Theory creates dietitian-formulated, third-party tested supplements designed to deliver real results. With transparency, science, and self-care at its core, Neue Theory is redefining what it means to feel good from the inside out - because Gut Care is Self-Care. Contact Information Ali Seller ali@ 647-825-8819 SOURCE: Neue Theory Wellness Corp. Neue Theory | Digest + Debloat Press Release | press release This story was originally published May 6, 2025 at 10:00 AM.
Business Standard
23-04-2025
- Business
- Business Standard
Delta Corp gains as Q4 PAT zooms 127% YoY to Rs 165 cr
Delta Corp added 1.05% to Rs 94.20 after the company's consolidated net profit zoomed 127.26% to Rs 164.56 crore in Q4 FY25 as against Rs 72.41 crore posted in Q4 FY24. However, revenue from operations declined 1.20% to Rs 182.65 crore in Q4 FY25, compared with Rs 184.87 crore posted in Q4 FY24. Profit before tax soared 142.80% to Rs 252.86 crore in Q4 FY25, compared with Rs 104.13 crore posted in Q4 FY24. Total expenses shed 0.73% YoY to Rs 154.06 crore during the quarter. The cost of material consumed stood at Rs 15.35 crore (down 35.42% YoY), and license & registration fees were at Rs 30.39 crore (down 1.04% YoY) during the period under review. On the segmental front, revenue from the casino gaming division fell 3.20% YoY to Rs 166.39 crore in Q4 FY25, while revenue from the hospitality division jumped 22.94% YoY to Rs 16.72 crore during the quarter. On a standalone basis, the companys net profit tumbled 31.52% to Rs 59.35 crore in Q4 FY25, compared with Rs 86.68 crore posted in Q4 FY24. Revenue from operations stood at Rs 146.54 crore in Q4 FY25, down 4.86% year on year. On a full-year basis, the company's net profit added 1.94% to Rs 248.99 crore despite a 13.98% decline in revenue from operations to Rs 729.63 crore in FY24 over FY23. For the year ended 31st March 2025, the company reported exceptional items amounting to Rs 213.22 crore. This includes a net gain of Rs 130.49 crore on the sale of 51% equity shares in its subsidiary, Deltatech Gaming (DGL). Following this transaction, DGL ceased to be a subsidiary and is now accounted for as an associate company under the equity method. Additionally, a gain of Rs 81.65 crore was recognized on the fair valuation of the remaining 49% stake in DGL. A further gain of Rs 1.08 crore arose from the strike-off of Delta Offshore Developers, a wholly owned and non-material foreign subsidiary. In the previous financial year, exceptional items stood at Rs 49.78 crore, which included a profit of Rs 58.79 crore from the sale of equity shares in Caravella Entertainment and a write-off of Rs 9.01 crore related to IPO expenses. Meanwhile, the companys board has recommended a final dividend of 125%, i.e., Rs 1.25 per equity share. The dividend will be paid by the company to the shareholders within 30 days from the date of approval of the same by the shareholders at the ensuing annual general meeting of the company. Delta Corp is the only listed company engaged in the casino (live, electronic, and online) gaming industry in India. The company is engaged in diversified segments like casino gaming, online gaming, hospitality, and real estate.
